BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37823316)

  • 1. Aldo-keto Reductase 1B10 Restrains Cell Migration, Invasion, and Adhesion of Gastric Cancer via Regulating Integrin Subunit Alpha 5.
    Yao H; Hu J; Shao Y; Shah Q; Zheng S
    Turk J Gastroenterol; 2023 Dec; 34(12):1197-1205. PubMed ID: 37823316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AKR1B10 inhibits the proliferation and migration of gastric cancer via regulating epithelial-mesenchymal transition.
    Shao X; Wu J; Yu S; Zhou Y; Zhou C
    Aging (Albany NY); 2021 Sep; 13(18):22298-22314. PubMed ID: 34552036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AKR1B10 promotes breast cancer metastasis through integrin α5/δ-catenin mediated FAK/Src/Rac1 signaling pathway.
    Huang C; Verhulst S; Shen Y; Bu Y; Cao Y; He Y; Wang Y; Huang D; Cai C; Rao K; Liao DF; Jin J; Cao D
    Oncotarget; 2016 Jul; 7(28):43779-43791. PubMed ID: 27248472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquisition of doxorubicin resistance facilitates migrating and invasive potentials of gastric cancer MKN45 cells through up-regulating aldo-keto reductase 1B10.
    Morikawa Y; Kezuka C; Endo S; Ikari A; Soda M; Yamamura K; Toyooka N; El-Kabbani O; Hara A; Matsunaga T
    Chem Biol Interact; 2015 Mar; 230():30-9. PubMed ID: 25686905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AKR1B10 promotes breast cancer cell migration and invasion via activation of ERK signaling.
    Li J; Guo Y; Duan L; Hu X; Zhang X; Hu J; Huang L; He R; Hu Z; Luo W; Tan T; Huang R; Liao D; Zhu YS; Luo DX
    Oncotarget; 2017 May; 8(20):33694-33703. PubMed ID: 28402270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown or inhibition of aldo-keto reductase 1B10 inhibits pancreatic carcinoma growth via modulating Kras-E-cadherin pathway.
    Zhang W; Li H; Yang Y; Liao J; Yang GY
    Cancer Lett; 2014 Dec; 355(2):273-80. PubMed ID: 25304374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of aldo-keto reductase 1B10 is an independent predictor of favorable prognosis in patients with hepatocellular carcinoma.
    Ha SY; Song DH; Lee JJ; Lee HW; Cho SY; Park CK
    Gut Liver; 2014 Nov; 8(6):648-54. PubMed ID: 25287169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression and oncogenic function of aldo-keto reductase family 1B10 (AKR1B10) in pancreatic carcinoma.
    Chung YT; Matkowskyj KA; Li H; Bai H; Zhang W; Tsao MS; Liao J; Yang GY
    Mod Pathol; 2012 May; 25(5):758-66. PubMed ID: 22222635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldo-Keto Reductases as Early Biomarkers of Hepatocellular Carcinoma: A Comparison Between Animal Models and Human HCC.
    Torres-Mena JE; Salazar-Villegas KN; Sánchez-Rodríguez R; López-Gabiño B; Del Pozo-Yauner L; Arellanes-Robledo J; Villa-Treviño S; Gutiérrez-Nava MA; Pérez-Carreón JI
    Dig Dis Sci; 2018 Apr; 63(4):934-944. PubMed ID: 29383608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of AKR1B10 promotes colorectal cancer cells proliferation and migration via regulating FGF1-dependent pathway.
    Yao Y; Wang X; Zhou D; Li H; Qian H; Zhang J; Jiang L; Wang B; Lin Q; Zhu X
    Aging (Albany NY); 2020 Jul; 12(13):13059-13075. PubMed ID: 32615540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulindac inhibits pancreatic carcinogenesis in LSL-KrasG12D-LSL-Trp53R172H-Pdx-1-Cre mice via suppressing aldo-keto reductase family 1B10 (AKR1B10).
    Li H; Yang AL; Chung YT; Zhang W; Liao J; Yang GY
    Carcinogenesis; 2013 Sep; 34(9):2090-8. PubMed ID: 23689354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of aldo-keto reductase family 1 member B10 in gastric cancer tissues and its clinical significance].
    Yao HB; Xu Y; Chen LG; Guan TP; Ma YY; Tao HQ; Shao QS
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Feb; 16(2):183-7. PubMed ID: 23446484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibiting proliferation and migration of lung cancer using small interfering RNA targeting on Aldo-keto reductase family 1 member B10.
    Zhou Z; Zhao Y; Gu L; Niu X; Lu S
    Mol Med Rep; 2018 Feb; 17(2):2153-2160. PubMed ID: 29207124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aldo-keto reductase family 1 B10 gene silencing results in growth inhibition of colorectal cancer cells: Implication for cancer intervention.
    Yan R; Zu X; Ma J; Liu Z; Adeyanju M; Cao D
    Int J Cancer; 2007 Nov; 121(10):2301-6. PubMed ID: 17597105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homeobox A5 activates p53 pathway to inhibit proliferation and promote apoptosis of adrenocortical carcinoma cells by inducing Aldo-Keto reductase family 1 member B10 expression.
    Chen D; Shen Z; Cheng X; Wang Q; Zhou J; Ren F; Sun Y; Wang H; Huang R
    Bioengineered; 2021 Dec; 12(1):1964-1975. PubMed ID: 34027794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat shock protein 90-α mediates aldo-keto reductase 1B10 (AKR1B10) protein secretion through secretory lysosomes.
    Luo D; Bu Y; Ma J; Rajput S; He Y; Cai G; Liao DF; Cao D
    J Biol Chem; 2013 Dec; 288(51):36733-40. PubMed ID: 24217247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ITGA5 Promotes Tumor Progression through the Activation of the FAK/AKT Signaling Pathway in Human Gastric Cancer.
    Wang JF; Chen YY; Zhang SW; Zhao K; Qiu Y; Wang Y; Wang JC; Yu Z; Li BP; Wang Z; Chen JQ
    Oxid Med Cell Longev; 2022; 2022():8611306. PubMed ID: 36193075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldo-keto reductase 1B10 promotes development of cisplatin resistance in gastrointestinal cancer cells through down-regulating peroxisome proliferator-activated receptor-γ-dependent mechanism.
    Matsunaga T; Suzuki A; Kezuka C; Okumura N; Iguchi K; Inoue I; Soda M; Endo S; El-Kabbani O; Hara A; Ikari A
    Chem Biol Interact; 2016 Aug; 256():142-53. PubMed ID: 27417252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AKR1B10 promotes breast cancer cell proliferation and migration via the PI3K/AKT/NF-κB signaling pathway.
    Qu J; Li J; Zhang Y; He R; Liu X; Gong K; Duan L; Luo W; Hu Z; Wang G; Xia C; Luo D
    Cell Biosci; 2021 Aug; 11(1):163. PubMed ID: 34419144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide confers cisplatin resistance in human lung cancer cells through upregulation of aldo-keto reductase 1B10 and proteasome.
    Matsunaga T; Yamaji Y; Tomokuni T; Morita H; Morikawa Y; Suzuki A; Yonezawa A; Endo S; Ikari A; Iguchi K; El-Kabbani O; Tajima K; Hara A
    Free Radic Res; 2014 Nov; 48(11):1371-85. PubMed ID: 25156503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.